TCWP’s Genmab GMAB Stock Holding History

TCWP’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-90	Closed	-$3K	–	849
2022 Q1	$3K	Buy	+90	New	+$3.09K	﹤0.01%	1193

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TCWP's GMAB Position: Q2 2022 in Review

TCWP sold out of Genmab (GMAB) in Q2 2022, closing a stake of 90 shares — an estimated $3K sold.

TCWP first reported a position in GMAB in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 180 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

TCWP reported no remaining Genmab position as of Q2 2022 after selling out during the quarter.
TCWP sold 90 Genmab shares in Q2 2022, an estimated $3K.
TCWP first reported a position in Genmab in Q1 2022 and held it in 1 quarter.
TCWP's Genmab position peaked at $3K in Q1 2022.
180 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.